<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Alpine Clinical Research Center</title>
	<atom:link href="http://www.alpineresearch.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.alpineresearch.com</link>
	<description>Researching New Medications for Your Future</description>
	<lastBuildDate>Tue, 23 Aug 2011 20:48:41 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>New Investigational Medication for Moderate to Severe Parkinson&#8217;s Disease</title>
		<link>http://www.alpineresearch.com/active/new-investigational-medication-for-moderate-to-severe-parkinsons-disease/</link>
		<comments>http://www.alpineresearch.com/active/new-investigational-medication-for-moderate-to-severe-parkinsons-disease/#comments</comments>
		<pubDate>Tue, 23 Aug 2011 20:39:51 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Active]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=284</guid>
		<description><![CDATA[A 12-week, Double-blind, Placebo-controlled Efficacy and Safety Study of Preladenant  for Patients with Moderate to Severe Parkinson&#8217;s Disease. Major Inclusion/Exclusion: Ages 30 to 85  Must have diagnosis of Idiopathic Parkinson&#8217;s Disease. Must currently be taking at least 1 year of ongoing therapy with Levodopa. Must not have any other form of Parkinson&#8217;s or cognitive impairment. Alpine Clinical Research Center 1000 [...]]]></description>
			<content:encoded><![CDATA[<p>A 12-week, Double-blind, Placebo-controlled Efficacy and Safety Study of Preladenant  for Patients with Moderate to Severe Parkinson&#8217;s Disease.</p>
<p><strong>Major Inclusion/Exclusion:</strong></p>
<ul>
<li>Ages 30 to 85 </li>
<li>Must have diagnosis of Idiopathic Parkinson&#8217;s Disease.</li>
<li>Must currently be taking at least 1 year of ongoing therapy with Levodopa.</li>
<li>Must not have any other form of Parkinson&#8217;s or cognitive impairment.</li>
</ul>
<p>Alpine Clinical Research Center<br />
1000 Alpine Avenue, Suite 200<br />
Boulder, CO 80304<br />
Phone: 303-443-7229<br />
Email: info@alpineresearch.com</p>
<p><a class="a2a_dd a2a_target addtoany_share_save" href="http://www.addtoany.com/share_save#url=http%3A%2F%2Fwww.alpineresearch.com%2Factive%2Fnew-investigational-medication-for-moderate-to-severe-parkinsons-disease%2F&amp;title=New%20Investigational%20Medication%20for%20Moderate%20to%20Severe%20Parkinson%26%238217%3Bs%20Disease" id="wpa2a_4"><img src="http://www.alpineresearch.com/wp-content/plugins/add-to-any/share_save_171_16.png" width="171" height="16" alt="Share"/></a></p>]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/active/new-investigational-medication-for-moderate-to-severe-parkinsons-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medication for Painful Diabetic Peripheral Neuropathy</title>
		<link>http://www.alpineresearch.com/active/medication-for-painful-diabetic-peripheral-neuropathy/</link>
		<comments>http://www.alpineresearch.com/active/medication-for-painful-diabetic-peripheral-neuropathy/#comments</comments>
		<pubDate>Fri, 22 Apr 2011 16:35:00 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Active]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=279</guid>
		<description><![CDATA[A 21 week study of Pregabalin (Lyrica®) for Patients with Inadequately Treated Painful Diabetic Peripheral Neuropathy. Major Inclusion/Exclusion: Ages 18 or older Must have had Painful Diabetic Neuropathy for at least 3 months. Must currently be taking medication for pain other than Opioids that is inadequately controlling their pain. Must not be currently taking pregabalin (Lyrica®). [...]]]></description>
			<content:encoded><![CDATA[<p>A 21 week study of Pregabalin (Lyrica®) for Patients with Inadequately Treated Painful Diabetic Peripheral Neuropathy.</p>
<p><strong>Major Inclusion/Exclusion:</strong></p>
<ul>
<li>Ages 18 or older</li>
<li>Must have had Painful Diabetic Neuropathy for at least 3 months.</li>
<li>Must currently be taking medication for pain other than Opioids that is inadequately controlling their pain.</li>
<li>Must not be currently taking pregabalin (Lyrica®).</li>
</ul>
<p>Alpine Clinical Research Center<br />
1000 Alpine Avenue, Suite 200<br />
Boulder, CO 80304<br />
Phone: 303-443-7229<br />
Email: info@alpineresearch.com</p>
<p><a class="a2a_dd a2a_target addtoany_share_save" href="http://www.addtoany.com/share_save#url=http%3A%2F%2Fwww.alpineresearch.com%2Factive%2Fmedication-for-painful-diabetic-peripheral-neuropathy%2F&amp;title=Medication%20for%20Painful%20Diabetic%20Peripheral%20Neuropathy" id="wpa2a_8"><img src="http://www.alpineresearch.com/wp-content/plugins/add-to-any/share_save_171_16.png" width="171" height="16" alt="Share"/></a></p>]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/active/medication-for-painful-diabetic-peripheral-neuropathy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protocol 109MS302, Biogen, Multiple Sclerosis</title>
		<link>http://www.alpineresearch.com/completed/protocol-109ms302-biogen-multiple-sclerosis/</link>
		<comments>http://www.alpineresearch.com/completed/protocol-109ms302-biogen-multiple-sclerosis/#comments</comments>
		<pubDate>Thu, 31 Mar 2011 15:37:00 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Completed]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=276</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/completed/protocol-109ms302-biogen-multiple-sclerosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protocol F1J-US-HMFR, Eli-Lilly, Neuropathic Pain in Multiple Sclerosis</title>
		<link>http://www.alpineresearch.com/completed/protocol-f1j-us-hmfr-eli-lilly-neuropathic-pain-in-multiple-sclerosis/</link>
		<comments>http://www.alpineresearch.com/completed/protocol-f1j-us-hmfr-eli-lilly-neuropathic-pain-in-multiple-sclerosis/#comments</comments>
		<pubDate>Thu, 31 Mar 2011 15:35:58 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Completed]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=274</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/completed/protocol-f1j-us-hmfr-eli-lilly-neuropathic-pain-in-multiple-sclerosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protocol F1J-US-HMGL, Eli Lilly, Osteoarthritis of the Knee</title>
		<link>http://www.alpineresearch.com/completed/protocol-f1j-us-hmgl-eli-lilly-osteoarthritis-of-the-knee/</link>
		<comments>http://www.alpineresearch.com/completed/protocol-f1j-us-hmgl-eli-lilly-osteoarthritis-of-the-knee/#comments</comments>
		<pubDate>Thu, 24 Mar 2011 19:33:01 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Completed]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=272</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/completed/protocol-f1j-us-hmgl-eli-lilly-osteoarthritis-of-the-knee/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protocol AZD2066, Astra Zeneca, Post Herpetic Neuralgia</title>
		<link>http://www.alpineresearch.com/completed/protocol-azd2066-astra-zeneca-post-herpetic-neuralgia/</link>
		<comments>http://www.alpineresearch.com/completed/protocol-azd2066-astra-zeneca-post-herpetic-neuralgia/#comments</comments>
		<pubDate>Thu, 24 Mar 2011 19:32:17 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Completed]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=270</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/completed/protocol-azd2066-astra-zeneca-post-herpetic-neuralgia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protocol ZX001-0901, Zogenix Inc., Migraine</title>
		<link>http://www.alpineresearch.com/completed/protocol-zx001-0901-zogenix-inc-migraine/</link>
		<comments>http://www.alpineresearch.com/completed/protocol-zx001-0901-zogenix-inc-migraine/#comments</comments>
		<pubDate>Thu, 24 Mar 2011 19:31:10 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Completed]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=268</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/completed/protocol-zx001-0901-zogenix-inc-migraine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protocol RG8-MD-02, Forest Labs, Diabetic Peripheral Neuropathy</title>
		<link>http://www.alpineresearch.com/completed/protocol-rg8-md-02-forest-labs-diabetic-peripheral-neuropathy/</link>
		<comments>http://www.alpineresearch.com/completed/protocol-rg8-md-02-forest-labs-diabetic-peripheral-neuropathy/#comments</comments>
		<pubDate>Thu, 24 Mar 2011 19:30:22 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Completed]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=266</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/completed/protocol-rg8-md-02-forest-labs-diabetic-peripheral-neuropathy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A4091031, Pfizer, Diabetic Peripheral Neuropathy</title>
		<link>http://www.alpineresearch.com/completed/a4091031-pfizer-diabetic-peripheral-neuropathy/</link>
		<comments>http://www.alpineresearch.com/completed/a4091031-pfizer-diabetic-peripheral-neuropathy/#comments</comments>
		<pubDate>Thu, 24 Mar 2011 19:29:14 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Completed]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=264</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/completed/a4091031-pfizer-diabetic-peripheral-neuropathy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protocol A4091039 Open Label, Chronic Low Back Pain</title>
		<link>http://www.alpineresearch.com/completed/protocol-a4091039-open-label-chronic-low-back-pain/</link>
		<comments>http://www.alpineresearch.com/completed/protocol-a4091039-open-label-chronic-low-back-pain/#comments</comments>
		<pubDate>Thu, 24 Mar 2011 19:28:42 +0000</pubDate>
		<dc:creator>AlpineResearch</dc:creator>
				<category><![CDATA[Completed]]></category>

		<guid isPermaLink="false">http://www.alpineresearch.com/?p=262</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.alpineresearch.com/completed/protocol-a4091039-open-label-chronic-low-back-pain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

